Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Zoetis Total Liabilities 2011-2024 | ZTS

Zoetis total liabilities from 2011 to 2024. Total liabilities can be defined as the total value of all possible claims against the corporation.
  • Zoetis total liabilities for the quarter ending December 31, 2024 were $9.467B, a 1.85% increase year-over-year.
  • Zoetis total liabilities for 2024 were $9.467B, a 1.85% increase from 2023.
  • Zoetis total liabilities for 2023 were $9.295B, a 11.66% decline from 2022.
  • Zoetis total liabilities for 2022 were $10.522B, a 12.46% increase from 2021.
  
Zoetis Annual Total Liabilities
(Millions of US $)
2024 $9,467
2023 $9,295
2022 $10,522
2021 $9,356
2020 $9,836
2019 $8,837
2018 $8,592
2017 $6,800
2016 $6,150
2015 $6,822
2014 $5,251
2013 $5,596
2012 $2,221
2011 $1,975
2010 $0
Zoetis Quarterly Total Liabilities
(Millions of US $)
2024-12-31 $9,467
2024-09-30 $9,123
2024-06-30 $9,205
2024-03-31 $9,296
2023-12-31 $9,295
2023-09-30 $9,032
2023-06-30 $9,128
2023-03-31 $9,263
2022-12-31 $10,522
2022-09-30 $9,012
2022-06-30 $9,190
2022-03-31 $9,202
2021-12-31 $9,356
2021-09-30 $9,024
2021-06-30 $9,717
2021-03-31 $9,704
2020-12-31 $9,836
2020-09-30 $10,118
2020-06-30 $10,082
2020-03-31 $8,775
2019-12-31 $8,837
2019-09-30 $8,594
2019-06-30 $8,575
2019-03-31 $8,566
2018-12-31 $8,592
2018-09-30 $8,341
2018-06-30 $6,621
2018-03-31 $6,715
2017-12-31 $6,800
2017-09-30 $7,269
2017-06-30 $6,056
2017-03-31 $6,014
2016-12-31 $6,150
2016-09-30 $6,117
2016-06-30 $6,147
2016-03-31 $6,266
2015-12-31 $6,822
2015-09-30 $5,432
2015-06-30 $5,396
2015-03-31 $5,125
2014-12-31 $5,251
2014-09-30 $5,138
2014-06-30 $5,239
2014-03-31 $5,304
2013-12-31 $5,596
2013-09-30 $5,393
2013-06-30 $5,438
2013-03-31 $5,418
2012-12-31 $2,221
2012-09-30 $0
2012-06-30 $0
2012-03-31 $0
2011-12-31 $1,975
2010-12-31 $0
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $68.972B $9.256B
Zoetis Inc. is a leader in the animal health space with a focus on both livestock and companion animals in seven major product categories: vaccines, anti-infectives, parasiticides, dermatology, other pharmaceutical products, medicated feed additives and animal health diagnostics. Zoetis has a diversified business, which caters to eight core species ' cattle, swine, poultry, fish and sheep (collectively, livestock) and dogs, cats and horses (collectively, companion animals). It directly markets its products to veterinarians and livestock producers. The outstanding growth rate in the companion animal medicines, vaccines and diagnostics sector is being driven by economic development, related increases in disposable income and a rise in pet ownership and spending on pet care.Zoetis has been working on strengthening its product portfolio through acquisitions and deals.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $82.901B 31.10
Daiichi Sankyo, - (DSNKY) Japan $43.624B 22.19
Takeda Pharmaceutical (TAK) Japan $43.624B 8.68
Sandoz Group AG (SDZNY) Switzerland $19.765B 0.00
Merck (MKKGY) Germany $17.939B 14.85
Summit Therapeutics (SMMT) United States $16.896B 0.00
United Therapeutics (UTHR) United States $13.518B 11.96
Shionogi (SGIOY) Japan $12.590B 12.61
Neurocrine Biosciences (NBIX) United States $11.755B 40.26
IPSEN (IPSEY) France $9.548B 0.00
Orion OYJ (ORINY) Finland $8.544B 23.11
Corcept Therapeutics (CORT) United States $7.512B 61.07
Stevanato Group S.p.A (STVN) Italy $7.183B 43.93
Madrigal Pharmaceuticals (MDGL) United States $6.280B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.976B 0.00
Grifols, S.A (GRFS) Spain $5.205B 0.00
Ionis Pharmaceuticals (IONS) United States $5.189B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.040B 10.32
Soleno Therapeutics (SLNO) United States $3.702B 0.00
Crinetics Pharmaceuticals (CRNX) United States $2.930B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.854B 10.00
Hypermarcas (HYPMY) Brazil $2.687B 17.67
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.278B 12.46
BioCryst Pharmaceuticals (BCRX) United States $2.061B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.059B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.752B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.639B 0.00
Guardian Pharmacy Services (GRDN) United States $1.527B 0.00
Indivior (INDV) United States $1.521B 6.45
Evotec AG (EVO) Germany $1.449B 0.00
Dyne Therapeutics (DYN) United States $1.330B 0.00
ARS Pharmaceuticals (SPRY) United States $1.188B 0.00
Ocular Therapeutix (OCUL) United States $1.104B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.061B 21.22
Enliven Therapeutics (ELVN) United States $0.976B 0.00
Collegium Pharmaceutical (COLL) United States $0.934B 5.04
Harrow (HROW) United States $0.922B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.824B 0.00
Cronos Group (CRON) Canada $0.794B 0.00
Ardelyx (ARDX) United States $0.785B 0.00
Xeris Biopharma Holdings (XERS) United States $0.726B 0.00
AleAnna (ANNA) United States $0.706B 0.00
Akebia Therapeutics (AKBA) United States $0.643B 0.00
Xencor (XNCR) United States $0.579B 0.00
KalVista Pharmaceuticals (KALV) United States $0.564B 0.00
USANA Health Sciences (USNA) United States $0.544B 11.83
Regulus Therapeutics (RGLS) United States $0.543B 0.00
CytoDyn (CYDY) United States $0.532B 0.00
Bioventus (BVS) United States $0.523B 13.29
Savara (SVRA) United States $0.517B 0.00
Relay Therapeutics (RLAY) United States $0.475B 0.00
Elite Pharmaceuticals (ELTP) United States $0.471B 0.00
Altimmune (ALT) United States $0.462B 0.00
Zevra Therapeutics (ZVRA) United States $0.445B 0.00
Siga Technologies (SIGA) United States $0.424B 8.85
Theravance Biopharma (TBPH) Cayman Islands $0.421B 0.00
Tourmaline Bio (TRML) United States $0.398B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.388B 0.00
Verve Therapeutics (VERV) United States $0.384B 0.00
Organogenesis (ORGO) United States $0.382B 0.00
Oruka Therapeutics (ORKA) United States $0.364B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.327B 8.83
Nature's Sunshine Products (NATR) United States $0.263B 24.29
Heron Therapeutics (HRTX) United States $0.262B 0.00
ProKidney (PROK) United States $0.226B 0.00
Aquestive Therapeutics (AQST) United States $0.221B 0.00
MediWound (MDWD) Israel $0.210B 0.00
OmniAb (OABI) United States $0.186B 0.00
Nanobiotix S.A (NBTX) France $0.183B 0.00
Avita Medical (RCEL) United States $0.177B 0.00
Liminatus Pharma (LIMN) $0.169B 0.00
Procaps Group, S.A (PROCF) Luxembourg $0.164B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.162B 0.00
Inhibikase Therapeutics (IKT) United States $0.158B 0.00
4D Molecular Therapeutics (FDMT) United States $0.145B 0.00
Esperion Therapeutics (ESPR) United States $0.145B 0.00
Journey Medical (DERM) United States $0.138B 0.00
Nektar Therapeutics (NKTR) United States $0.133B 0.00
Korro Bio (KRRO) United States $0.133B 0.00
Aldeyra Therapeutics (ALDX) United States $0.130B 0.00
Wellgistics Health (WGRX) United States $0.129B 0.00
Aclaris Therapeutics (ACRS) United States $0.128B 0.00
Innate Pharma SA (IPHYF) France $0.122B 0.00
Profound Medical (PROF) Canada $0.121B 0.00
Protara Therapeutics (TARA) United States $0.121B 0.00
Lyell Immunopharma (LYEL) United States $0.115B 0.00
Larimar Therapeutics (LRMR) United States $0.115B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.111B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.105B 0.00
OptiNose (OPTN) United States $0.095B 0.00
Cardiol Therapeutics (CRDL) Canada $0.092B 0.00
VAXART, INC (VXRT) United States $0.091B 0.00
Cassava Sciences (SAVA) United States $0.091B 0.00
Champions Oncology (CSBR) United States $0.089B 14.70
Lexeo Therapeutics (LXEO) United States $0.089B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.086B 0.00
Achieve Life Sciences (ACHV) Canada $0.086B 0.00
Dominari Holdings (DOMH) United States $0.085B 0.00
Galectin Therapeutics (GALT) United States $0.082B 0.00
Arch Biopartners (ACHFF) Canada $0.080B 0.00
Telomir Pharmaceuticals (TELO) United States $0.079B 0.00
ESSA Pharma (EPIX) Canada $0.076B 0.00
Fractyl Health (GUTS) United States $0.075B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.074B 55.11
Context Therapeutics (CNTX) United States $0.071B 0.00
Inotiv (NOTV) United States $0.070B 0.00
Unicycive Therapeutics (UNCY) United States $0.067B 0.00
Pyxis Oncology (PYXS) United States $0.066B 0.00
Nutriband (NTRB) United States $0.063B 0.00
Vivani Medical (VANI) United States $0.060B 0.00
Assertio Holdings (ASRT) United States $0.059B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Metagenomi (MGX) United States $0.056B 0.00
Gain Therapeutics (GANX) United States $0.055B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.050B 0.00
Mural Oncology (MURA) Ireland $0.044B 0.00
PMV Pharmaceuticals (PMVP) United States $0.044B 0.00
Century Therapeutics (IPSC) United States $0.042B 0.00
Karyopharm Therapeutics (KPTI) United States $0.042B 0.00
Prelude Therapeutics (PRLD) United States $0.039B 0.00
NRx Pharmaceuticals (NRXP) United States $0.039B 0.00
Avalo Therapeutics (AVTX) United States $0.039B 0.00
Iterum Therapeutics (ITRM) Ireland $0.038B 0.00
SCYNEXIS (SCYX) United States $0.037B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.037B 0.00
Acrivon Therapeutics (ACRV) United States $0.036B 0.00
Rafael Holdings (RFL) United States $0.035B 0.00
ElectroCore (ECOR) United States $0.034B 0.00
FibroGen (FGEN) United States $0.030B 0.00
PolyPid (PYPD) Israel $0.030B 0.00
Enlivex Therapeutics (ENLV) Israel $0.024B 0.00
Tempest Therapeutics (TPST) United States $0.024B 0.00
CASI Pharmaceuticals (CASI) China $0.023B 0.00
Mannatech (MTEX) United States $0.022B 0.00
Surrozen (SRZN) United States $0.021B 0.00
BioVie (BIVI) United States $0.020B 0.00
Jupiter Neurosciences (JUNS) United States $0.020B 0.00
DURECT (DRRX) United States $0.020B 0.00
Natural Alternatives (NAII) United States $0.020B 0.00
VYNE Therapeutics (VYNE) United States $0.019B 0.00
Vivos Therapeutics (VVOS) United States $0.018B 0.00
Lipocine (LPCN) United States $0.017B 0.00
TherapeuticsMD (TXMD) United States $0.017B 0.00
Ernexa Therapeutics (ERNA) United States $0.015B 0.00
GlycoMimetics (GLYC) United States $0.015B 0.00
ProPhase Labs (PRPH) United States $0.015B 0.00
MEI Pharma (MEIP) United States $0.015B 0.00
Relmada Therapeutics (RLMD) United States $0.014B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.013B 0.00
Cosmos Health (COSM) United States $0.012B 0.00
Scienture Holdings (SCNX) United States $0.012B 0.00
Minerva Neurosciences (NERV) United States $0.011B 1.88
Talphera (TLPH) United States $0.010B 0.00
BioLineRx (BLRX) Israel $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
Citius Pharmaceuticals (CTXR) United States $0.009B 0.00
Plus Therapeutics (PSTV) United States $0.009B 0.00
Biomerica (BMRA) United States $0.009B 0.00
Phio Pharmaceuticals (PHIO) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Ainos (AIMD) United States $0.008B 0.00
Klotho Neurosciences (KLTO) United States $0.008B 0.00
Mangoceuticals (MGRX) United States $0.008B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
Carisma Therapeutics (CARM) United States $0.008B 0.00
Lyra Therapeutics (LYRA) United States $0.007B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
Indaptus Therapeutics (INDP) United States $0.007B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.007B 0.00
Traws Pharma (TRAW) United States $0.007B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.006B 0.00
Aptorum Group (APM) United Kingdom $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.005B 0.00
Conduit Pharmaceuticals (CDT) United States $0.005B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
InMed Pharmaceuticals (INM) Canada $0.004B 0.00
PainReform (PRFX) Israel $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
Redhill Biopharma (RDHL) Israel $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.001B 0.00
Heatwurx (PCSA) United States $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.001B 0.00
SHINECO (SISI) China $0.001B 0.00
Petros Pharmaceuticals (PTPI) United States $0.000B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Aditxt (ADTX) United States $0.000B 0.00
Incannex Healthcare (IXHL) Australia $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00